The US Biosecure Act approved by the House of Representatives on Tuesday has drawn harsh criticism from concerned Chinese companies global pharma ...

Several leading global biopharmaceutical companies, such as Merck, Gilead Sciences and Vertex Pharmaceuticals, have identified potential repercussions of the Biosecure Act, including higher expenses, ...

Acetonitrile, methanol, and formic acid (chromatography pure) were procured from Merck (Germany). AN and CAN were obtained ... were detected using an ELISA kit from Nanjing Jiancheng Bioengineering ...

In an email, the company pointed out that the majority of patients in LITESPARK-005 received Welireg as their third or fourth-line treatment (87.4%) after being treated with PD-1/L1 inhibitor and ...

The Committee for Medicinal Products for Human Use recommends marketing approval for Merck's Keytruda for treating two types of gynecologic cancers. The FDA approves MRK's Keytruda for first-line ...

In 2021, the FDA blasted Merck for using a premature endpoint to pursue a Keytruda approval in early-stage triple-negative breast cancer (TNBC). Now, the PD-1 inhibitor has gold-standard overall ...

Merck & Co.’s best-selling drug Keytruda helped women with a hard-to-treat form of breast cancer live longer, according to the first study to show such a benefit in these patients. After five ...

What’s next for Akeso and Summit Therapeutics after their cancer immunotherapy outperformed Merck’s Keytruda in a large Phase 3 clinical trial? Who’s the iconoclastic outsider behind Summit ...